口服乙酰唑胺使紫杉醇引起的黄斑病变消退。 - Suppr

Suppr

超能文献

Regression of paclitaxel-induced maculopathy with oral acetazolamide.

作者信息

Meyer Kerstin Maria, Klink Thomas, Ugurel Selma, Bröcker Eva-Bettina

出版信息

Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):463-4. doi: 10.1007/s00417-011-1642-8. Epub 2011 Mar 23.

DOI:10.1007/s00417-011-1642-8

PMID:21431400

Abstract

摘要

相似文献

Regression of paclitaxel-induced maculopathy with oral acetazolamide.

Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):463-4. doi: 10.1007/s00417-011-1642-8. Epub 2011 Mar 23.

Acetazolamide in the treatment of X-linked retinoschisis maculopathy.

Arch Ophthalmol. 2007 Apr;125(4):571-3. doi: 10.1001/archopht.125.4.571.

A case of cystoid macular edema associated with Paclitaxel chemotherapy.

Korean J Ophthalmol. 2012 Oct;26(5):388-90. doi: 10.3341/kjo.2012.26.5.388. Epub 2012 Sep 12.

POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.

Retin Cases Brief Rep. 2018;12(1):75-79. doi: 10.1097/ICB.0000000000000433.

Non-leaking Cystoid Maculopathy Secondary to Systemic Paclitaxel.

Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr;44(2):183-6. doi: 10.3928/23258160-20130218-01. Epub 2013 Feb 22.

Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide.

Can J Ophthalmol. 2016 Aug;51(4):e113-e115. doi: 10.1016/j.jcjo.2015.12.021.

A case of paclitaxel-induced maculopathy treated with methazolamide.

Korean J Ophthalmol. 2012 Oct;26(5):394-7. doi: 10.3341/kjo.2012.26.5.394. Epub 2012 Sep 24.

Significant macular edema in a patient with cone dystrophy and improvement with acetazolamide treatment.

Retin Cases Brief Rep. 2014 Fall;8(4):300-5. doi: 10.1097/ICB.0000000000000058.

Bilateral cystoid macular edema in a patient with taxane-based chemotherapy.

Can J Ophthalmol. 2013 Feb;48(1):e3-4. doi: 10.1016/j.jcjo.2012.08.013.

Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.

Retina. 1997;17(3):222-31. doi: 10.1097/00006982-199705000-00009.

引用本文的文献

Efficacy of topical carbonic anhydrase inhibitors in treating taxane drug-induced cystoid macular edema: A case report.

Medicine (Baltimore). 2025 Jan 3;104(1):e40958. doi: 10.1097/MD.0000000000040958.

Safety signals of albumin-bound paclitaxel: Data mining of the Food and Drug Administration adverse event reporting system.

Indian J Pharmacol. 2023 May-Jun;55(3):167-173. doi: 10.4103/ijp.ijp_640_22.

Retinal phototoxicity after macular hole surgery in a patient under paclitaxel.

BMC Ophthalmol. 2023 Aug 1;23(1):342. doi: 10.1186/s12886-023-03086-x.

Taxane-Induced Neuropathy and Its Ocular Effects-A Longitudinal Follow-up Study in Breast Cancer Patients.

Cancers (Basel). 2023 Apr 25;15(9):2444. doi: 10.3390/cancers15092444.

Cystoid macular oedema without leakage in fluorescein angiography: a literature review.

Eye (Lond). 2023 Jun;37(8):1519-1526. doi: 10.1038/s41433-022-02230-z. Epub 2022 Sep 10.

Paclitaxel may be a risk factor for retinal phototoxicity.

Am J Ophthalmol Case Rep. 2022 Jan 20;25:101292. doi: 10.1016/j.ajoc.2022.101292. eCollection 2022 Mar.

Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.

J Med Case Rep. 2021 Jul 21;15(1):355. doi: 10.1186/s13256-021-02954-8.

Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.

Am J Ophthalmol Case Rep. 2020 Mar 7;18:100653. doi: 10.1016/j.ajoc.2020.100653. eCollection 2020 Jun.

Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.

BMJ Case Rep. 2016 Apr 19;2016:10.1136/bcr-2015-212733. doi: 10.1136/bcr-2015-212733.

Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports.

Ophthalmol Eye Dis. 2014 May 27;6:21-6. doi: 10.4137/OED.S13617. eCollection 2014.

本文引用的文献

Cystoid macular edema secondary to nab-paclitaxel therapy.

J Clin Oncol. 2010 Nov 20;28(33):e684-7. doi: 10.1200/JCO.2010.30.3750. Epub 2010 Aug 30.

[A case of cystic maculopathy during paclitaxel therapy].

Nippon Ganka Gakkai Zasshi. 2010 Jan;114(1):23-7.

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.

J Clin Oncol. 2009 Jun 10;27(17):2823-30. doi: 10.1200/JCO.2007.15.7636. Epub 2009 Apr 6.

Paclitaxel maculopathy.

Arch Ophthalmol. 2007 May;125(5):709-10. doi: 10.1001/archopht.125.5.709.

Ophthalmic toxicity following paclitaxel infusion.

Ann Oncol. 1997 Oct;8(10):1053. doi: 10.1023/a:1008249230056.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Regression of paclitaxel-induced maculopathy with oral acetazolamide.

作者信息

Meyer Kerstin Maria, Klink Thomas, Ugurel Selma, Bröcker Eva-Bettina

出版信息

Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):463-4. doi: 10.1007/s00417-011-1642-8. Epub 2011 Mar 23.

DOI:10.1007/s00417-011-1642-8

PMID:21431400

Abstract

摘要

相似文献

Regression of paclitaxel-induced maculopathy with oral acetazolamide.

Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):463-4. doi: 10.1007/s00417-011-1642-8. Epub 2011 Mar 23.

Acetazolamide in the treatment of X-linked retinoschisis maculopathy.

Arch Ophthalmol. 2007 Apr;125(4):571-3. doi: 10.1001/archopht.125.4.571.

A case of cystoid macular edema associated with Paclitaxel chemotherapy.

Korean J Ophthalmol. 2012 Oct;26(5):388-90. doi: 10.3341/kjo.2012.26.5.388. Epub 2012 Sep 12.

POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.

Retin Cases Brief Rep. 2018;12(1):75-79. doi: 10.1097/ICB.0000000000000433.

Non-leaking Cystoid Maculopathy Secondary to Systemic Paclitaxel.

Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr;44(2):183-6. doi: 10.3928/23258160-20130218-01. Epub 2013 Feb 22.

Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide.

Can J Ophthalmol. 2016 Aug;51(4):e113-e115. doi: 10.1016/j.jcjo.2015.12.021.

A case of paclitaxel-induced maculopathy treated with methazolamide.

Korean J Ophthalmol. 2012 Oct;26(5):394-7. doi: 10.3341/kjo.2012.26.5.394. Epub 2012 Sep 24.

Significant macular edema in a patient with cone dystrophy and improvement with acetazolamide treatment.

Retin Cases Brief Rep. 2014 Fall;8(4):300-5. doi: 10.1097/ICB.0000000000000058.

Bilateral cystoid macular edema in a patient with taxane-based chemotherapy.

Can J Ophthalmol. 2013 Feb;48(1):e3-4. doi: 10.1016/j.jcjo.2012.08.013.

Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.

Retina. 1997;17(3):222-31. doi: 10.1097/00006982-199705000-00009.

引用本文的文献

Efficacy of topical carbonic anhydrase inhibitors in treating taxane drug-induced cystoid macular edema: A case report.

Medicine (Baltimore). 2025 Jan 3;104(1):e40958. doi: 10.1097/MD.0000000000040958.

Safety signals of albumin-bound paclitaxel: Data mining of the Food and Drug Administration adverse event reporting system.

Indian J Pharmacol. 2023 May-Jun;55(3):167-173. doi: 10.4103/ijp.ijp_640_22.

Retinal phototoxicity after macular hole surgery in a patient under paclitaxel.

BMC Ophthalmol. 2023 Aug 1;23(1):342. doi: 10.1186/s12886-023-03086-x.

Taxane-Induced Neuropathy and Its Ocular Effects-A Longitudinal Follow-up Study in Breast Cancer Patients.

Cancers (Basel). 2023 Apr 25;15(9):2444. doi: 10.3390/cancers15092444.

Cystoid macular oedema without leakage in fluorescein angiography: a literature review.

Eye (Lond). 2023 Jun;37(8):1519-1526. doi: 10.1038/s41433-022-02230-z. Epub 2022 Sep 10.

Paclitaxel may be a risk factor for retinal phototoxicity.

Am J Ophthalmol Case Rep. 2022 Jan 20;25:101292. doi: 10.1016/j.ajoc.2022.101292. eCollection 2022 Mar.

Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.

J Med Case Rep. 2021 Jul 21;15(1):355. doi: 10.1186/s13256-021-02954-8.

Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.

Am J Ophthalmol Case Rep. 2020 Mar 7;18:100653. doi: 10.1016/j.ajoc.2020.100653. eCollection 2020 Jun.

Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.

BMJ Case Rep. 2016 Apr 19;2016:10.1136/bcr-2015-212733. doi: 10.1136/bcr-2015-212733.

Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports.

Ophthalmol Eye Dis. 2014 May 27;6:21-6. doi: 10.4137/OED.S13617. eCollection 2014.

本文引用的文献

Cystoid macular edema secondary to nab-paclitaxel therapy.

J Clin Oncol. 2010 Nov 20;28(33):e684-7. doi: 10.1200/JCO.2010.30.3750. Epub 2010 Aug 30.

[A case of cystic maculopathy during paclitaxel therapy].

Nippon Ganka Gakkai Zasshi. 2010 Jan;114(1):23-7.

J Clin Oncol. 2009 Jun 10;27(17):2823-30. doi: 10.1200/JCO.2007.15.7636. Epub 2009 Apr 6.

Paclitaxel maculopathy.

Arch Ophthalmol. 2007 May;125(5):709-10. doi: 10.1001/archopht.125.5.709.

Ophthalmic toxicity following paclitaxel infusion.

Ann Oncol. 1997 Oct;8(10):1053. doi: 10.1023/a:1008249230056.